Search - Prime Therapeutics

145 Results for Fraud Focus

Prime Therapeutics GLP-1 research at AMCP offers additional perspectives to obesity treatment

Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members

PA Sub-Categories: GLP-1 Prime Article: Perspectives
Prime Therapeutics sets forth new formulary recommendations to increase affordability with several new Humira® biosimilars

Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.

PA Sub-Categories: Specialty drugs Prime Article: Press Releases
Prime Therapeutics experts share their brilliance at annual specialty pharmacy event

Event features discussions about health care industry trends, best practices and innovations

PA Sub-Categories: Specialty drugs Prime Article: Stories
Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

Findings also show improved persistence with high-potency, obesity-approved GLP-1 products

PA Sub-Categories: GLP-1 Prime Article: Press Releases